{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:16:57Z","timestamp":1760908617121,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","semthorcardiovascsurg.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1053\/j.semtcvs.2021.08.023","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T22:16:55Z","timestamp":1630534615000},"page":"1049-1050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Commentary: Why Do Stage I Patients Die From Lung Cancer?"],"prefix":"10.1053","volume":"34","author":[{"given":"Andrea S.","family":"Wolf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.semtcvs.2021.08.023_bib0001","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1053\/j.semtcvs.2021.06.023","article-title":"Nomogram to predict cancer specific survival in patients with pathological stage IA non-small cell lung cancer","volume":"34","author":"Cai","year":"2022","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semtcvs.2021.08.023_bib0002","doi-asserted-by":"crossref","unstructured":"Henschke CI, McCauley DI, Yankelevitz DF, et al: Early lung cancer action project: overall design and findings from baseline screening. Lancet. 1999;354:99-105. https:\/\/doi.org\/10.1016\/S0140-6736(99)06093-6","DOI":"10.1016\/S0140-6736(99)06093-6"},{"key":"10.1053\/j.semtcvs.2021.08.023_bib0003","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semtcvs.2021.08.023_bib0004","first-page":"363","article-title":"Cancer treatment and survivorship statistics, 2019","volume":"69","author":"Miller","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.semtcvs.2021.08.023_bib0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.semtcvs.2021.08.023_bib0006","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.chest.2020.08.2048","article-title":"Survival following detection of stage i lung cancer by screening in the national lung screening trial","volume":"159","author":"Gierada","year":"2021","journal-title":"Chest"},{"key":"10.1053\/j.semtcvs.2021.08.023_bib0007","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jtcvs.2018.11.124","article-title":"Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non-small cell lung cancer","volume":"158","author":"Bott","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semtcvs.2021.08.023_bib0008","unstructured":"clinicaltrials.gov. Accessed 8.18.21"},{"key":"10.1053\/j.semtcvs.2021.08.023_bib0009","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1200\/JCO.2008.16.4855","article-title":"Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the cancer and leukemia group b, radiation therapy oncology group, and north central cancer treatment group study groups","volume":"26","author":"Strauss","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semtcvs.2021.08.023_bib0010","doi-asserted-by":"crossref","first-page":"254","DOI":"10.6004\/jnccn.2021.0013","article-title":"NCCN Guidelines insights: non-small cell lung cancer, version 2.2021","volume":"19","author":"Ettinger","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1053\/j.semtcvs.2021.08.023_bib0011","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa2027071","article-title":"Osimertinib in resected EGFR-mutated non-small-cell lung cancer","volume":"383","author":"Wu","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semtcvs.2021.08.023_bib0012","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature22364","article-title":"Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution","volume":"545","author":"Abbosh","year":"2017","journal-title":"Nature"}],"container-title":["Seminars in Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043067921004020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043067921004020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:32:06Z","timestamp":1760905926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043067921004020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"alternative-id":["S1043067921004020"],"URL":"https:\/\/doi.org\/10.1053\/j.semtcvs.2021.08.023","relation":{},"ISSN":["1043-0679"],"issn-type":[{"type":"print","value":"1043-0679"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Commentary: Why Do Stage I Patients Die From Lung Cancer?","name":"articletitle","label":"Article Title"},{"value":"Seminars in Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semtcvs.2021.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1053\/j.semtcvs.2021.06.023","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}